RT @MeralElRamahiMD: Post-Hoc of ASCORE trial: â¡ï¸RA w/ mod-high dz on SQ ABAtacept as 1st line tx w/ better retentio
Tweet Content
Post-Hoc of ASCORE trial:
➡️RA w/ mod-high dz on SQ ABAtacept as 1st line tx w/ better retention vs receiving it as 2nd line tx independent of b/l duration of dz
➤Do you use ABA as 1st line treatment for RA, when/if insurance allows? Comment below!
Abst#0816 #ACR21 @RheumNow https://t.co/TRJga4OfiW
Show on Archive Page
On
Display in Search Results
On
PDQ
Off